Scope of the Study
Due to upsurging research and developments in developing a number of novel therapies, an animal model market will show significant growth over the forecasted period. In addition to this, growing need to innovate and develop new types of novel drugs in order to cope up with the upsurging demand will further improve demand for animal species as a sample. Moreover, over the last few decades, a variety of genetic disorders have been raised across the globe, thus the need to carry out research studies of those diseases and human pathology will further escalate the demand for Aminal Model. Any animal species are performed and tested and chosen for pathological and biological studies are known as animal models. These models are utilized on the back of their functional resemblance to human bodies. However, various guidelines and stringent government regulations have restricted the applications of animal models.
The market study is being classified by Type (Rats, Mice, Rabbits, Dogs, Pigs, Cats and Others), by Application (Physiology, Toxicology, Cancer Research, Neurological Research, Biomedical Research, Genetic Research and Xenotransplantation) and major geographies with country level break-up. According to AMA, the Global Animal Model market is expected to see growth rate of 7.38% and may see market size of USD2618.8 Million by 2024.
Charles River Laboratories International, Inc. (United States), Horizon Discovery Group plc (United Kingdom), Advinus Therapeutics Limited (India), Jackson Laboratory (United States), Trans Genic Inc. (Japan), Taconic Biosciences, Inc. (United States), Genoway SA (France), Eurofins Scientific SE (Luxembourg), Crown Bioscience, Inc. (United States) and Envigo CRS SA (Spain) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Beijing Vital Star Biotechnology (China), Pharmalegacy Biotechnology (China) and Pharmaron, Inc. (United States).
The Players having a strong hold in the market are Charles River, Horizon Discovery, Advinus Therapeutics, Jackson Laboratory, and Trans Genic. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Animal Model market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Animal Model market by Type, Application and Region.
On the basis of geography, the market of Animal Model has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Academic & Research Institutions will boost the Animal Model market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Upsurging Research and Developments in Developing a Number of Novel Therapies
- Growing Need to Innovate and Develop New Types of Novel Drugs
- Increasing Adoption of Mouse Models in the Field of Cancer Research
- Development of Animal Models to Understand the Bases of Memory and Decision Making
- Comparatively Higher Costs Associated with Animal Model-Based Research
- Stringent Government Regulations on the Use of Animal Species for Reseach and Developments
- Rising Need for Animal Models for the Treatment of Alzheimer’s Disease
- Avails a Better Understanding of the Disease
- Lack of R&D Activities in Underdeveloped Economies
- Hard to Cope up with the Volatile Demand for Animal Model
Market Leaders and their expansionary development strategies
In July 2017, Pharmatest Services had partnered with Taconic Biosciences in a bid to manufacture a new tentative mouse model with a human immune system, precisely made to research bone metastasis. Scientists of the Center for Infectious Disease Research (CIDR) have also discovered an antibody preventing malaria using a unique humanized mouse liver model.
According to the World Health Organization (WHO), currently, dementia affects nearly 10 million people in Europe and is likely to double by 2030. Growing instances of neurological disorders in the European region is assisting the research and development activities using various biotechnological solutions such as highering Animal Model. In addition to this, the European Research Council has also established an advanced project named ‘CONCEPT’ in order to understand bases of memory, decision making, and perception using rodents and other technically advanced instruments.
Key Target AudienceAnimal Model Providers, Animal Model Distributors and Traders, Biotechnology Industry Associations, Pharmaceutical Organizations, Academic and Research Institutions, Government Agencies, Animal Husbandries and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase